Jianmin Wu

Eli Lilly and Company

Poster(s):

• P5478 - Incremental Improvement in Bowel Urgency Was Associated With Improved Patient-Reported Outcomes: Post Hoc Results From LUCENT-1 and -2 Trials
  Tuesday, October 28, 2025

  10:30 AM - 4:00 PM PDT

• P5479 - Mirikizumab Long-Term Impact on Bowel Urgency in Crohn’s Disease and Its Association With Clinical and Other Efficacy Outcomes: Results From the VIVID-2 Open-Label Extension Study
  Tuesday, October 28, 2025

  10:30 AM - 4:00 PM PDT